25M Health

In the vibrant landscape of health technology investment, 25M Health stands out as a dynamic venture studio and fund based in New York. This innovative joint venture is the collective effort of LifePoint Health, 25madison, and Apollo Global Management, embodying a unique synthesis of expertise and ambition. At its core, 25M Health thrives on its strategic partnership with LifePoint executives, facilitating a coincubation model that provides startups with unparalleled access to a substantial health system with revenue exceeding $50 billion. Navigating the intricate realms of preseed, seed, Series A, and Series B plus rounds, 25M Health positions itself as a champion for transformative ideas in health, software as a service, artificial intelligence, and consumerfocused enterprise solutions. In seeking to address the operational and clinical challenges faced by community hospitals, this fund places a commendable emphasis on serving historically underserved populations, including Medicaid patients, women over 40, and critical mental health demographics. As the healthcare landscape adapts to the remnants of a postCOVID world, 25M Health remains acutely attuned to regulatory and behavioral shifts that present both challenges and opportunities. This forwardthinking strategy not only aids in the pilot deployment of new technologies but also ensures realworld validation of the most promising innovations. The firm is driven by an unwavering commitment to improving health outcomes, providing a platform for startups to engage directly with real issues affecting communities. With an open door to collaboration and resources, 25M Health exemplifies the potential of venture capital in reshaping healthcare delivery. In an environment where adaptability is paramount, this investment firm is not just capitalizing on trends; it is pioneering meaningful change in a sector ripe for disruption.